$EVTV
Envirotech Vehicles, Inc. Stock $evtv

$evtv Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000143774924009818 Filed on March 28, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$810.5K	$106.8K	$2.863M
YoY Change	54.91%	-94.32%	-36.45%
Cost Of Revenue	$502.3K	$118.3K	$1.857M
YoY Change	24.07%	-89.89%	-33.02%
Gross Profit	$308.2K	-$11.52K	$1.006M
YoY Change	160.4%	-101.62%	-41.94%
Gross Profit Margin	38.03%	-10.79%	35.13%
Selling, General & Admin	$3.194M	$1.392M	$8.385M
YoY Change	36.51%	-28.98%	0.54%
% of Gross Profit	1036.36%		833.87%
Research & Development	$70.27K	$60.64K	$236.2K
YoY Change	-0.88%	51.6%	57.55%
% of Gross Profit	22.8%		23.49%
Depreciation & Amortization	$39.21K	$35.06K	$128.8K
YoY Change	35.29%	-12.35%	32.45%
% of Gross Profit	12.72%		12.81%
Operating Expenses	$3.265M	$1.453M	$8.621M
YoY Change	35.39%	-27.37%	-81.08%
Operating Profit	-$2.956M	-$1.464M	-$7.616M
YoY Change	28.93%	13.5%	-82.63%
Interest Expense	-$6.143K	-$8.620K	$34.84K
YoY Change	-119.11%	-186.2%	-22.62%
% of Operating Profit
Other Income/Expense, Net	-$1.576M	$5.750K	-$4.160K
YoY Change	-6414.87%	-42.5%	-109.62%
Pretax Income	-$4.532M	-$3.174M	-$12.68M
YoY Change	99.85%	-91.73%	-71.04%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$4.532M	-$3.174M	-$12.68M
YoY Change	99.85%	-91.73%	-71.04%
Net Earnings / Revenue	-559.21%	-2972.95%	-443.05%
Basic Earnings Per Share	-$0.29		-$0.84
Diluted Earnings Per Share	-$0.29	-$0.21	-$0.84
COMMON SHARES
Basic Shares Outstanding	15.52M	15.11M	15.06M
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.049M	$456.7K	$456.7K
YoY Change	-60.82%	-91.05%	-91.04%
Cash & Equivalents	$1.049M	$456.7K	$456.7K
Short-Term Investments		$0.00	$0.00
Other Short-Term Assets	$136.7K	$4.077M	$4.077M
YoY Change	-24.08%	2505.67%	-25.88%
Inventory	$7.241M	$6.831M	$6.831M
Prepaid Expenses	$357.2K	$614.2K
Receivables	$1.025M	$692.1K	$692.1K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$12.64M	$12.06M	$12.06M
YoY Change	-20.96%	-34.26%	-34.26%
LONG-TERM ASSETS
Property, Plant & Equipment	$309.5K	$859.6K	$859.6K
YoY Change	-13.79%	133.3%	132.33%
Goodwill	$9.584M	$9.584M
YoY Change	-34.73%	-34.73%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$160.2K	$153.6K	$153.6K
YoY Change	71.53%	64.47%	70.62%
Total Long-Term Assets	$10.52M	$10.60M	$10.60M
YoY Change	-30.49%	-30.03%	-30.01%
TOTAL ASSETS
Total Short-Term Assets	$12.64M	$12.06M	$12.06M
Total Long-Term Assets	$10.52M	$10.60M	$10.60M
Total Assets	$23.16M	$22.65M	$22.65M
YoY Change	-25.59%	-32.35%	-32.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$960.1K	$760.8K	$760.8K
YoY Change	8.61%	26.01%	26.8%
Accrued Expenses	$647.0K	$743.5K	$743.5K
YoY Change	80.8%	13.94%	14.38%
Deferred Revenue
YoY Change
Short-Term Debt	$1.027M	$0.00	$0.00
YoY Change
Long-Term Debt Due	$112.5K	$269.3K	$269.3K
YoY Change	87.53%	22.39%	22.39%
Total Short-Term Liabilities	$4.495M	$1.774M	$1.774M
YoY Change	245.23%	20.48%	20.65%
LONG-TERM LIABILITIES
Long-Term Debt	$8.860K	$10.42K	$10.42K
YoY Change	-55.7%	-47.9%	-47.9%
Other Long-Term Liabilities	$155.0K	$235.6K	$235.6K
YoY Change
Total Long-Term Liabilities	$163.9K	$246.1K	$246.1K
YoY Change	719.4%		1130.25%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.495M	$1.774M	$1.774M
Total Long-Term Liabilities	$163.9K	$246.1K	$246.1K
Total Liabilities	$4.658M	$2.020M	$2.020M
YoY Change	253.71%	35.66%	35.54%
SHAREHOLDERS EQUITY
Retained Earnings	-$69.14M	-$64.61M
YoY Change	27.58%	24.43%
Common Stock	$155.00	$152.00
YoY Change	3.33%	1.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$18.51M	$20.63M	$20.63M
YoY Change
Total Liabilities & Shareholders Equity	$23.16M	$22.65M	$22.65M
YoY Change	-25.59%	-32.35%	-32.34%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$4.532M	-$3.174M	-$12.68M
YoY Change	99.85%	-91.73%	-71.04%
Depreciation, Depletion And Amortization	$39.21K	$35.06K	$128.8K
YoY Change	35.29%	-12.35%	32.45%
Cash From Operating Activities	-$735.6K	-$205.5K	-$4.245M
YoY Change	-67.29%	-124.47%	-42.88%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	-$520.00	$35.81K
YoY Change	-100.0%	-100.65%	-78.76%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$2.343M
YoY Change	-100.0%	-100.0%	-58.76%
Cash From Investing Activities	$0.00	$520.00	$2.307M
YoY Change	-100.0%	-100.12%	-58.12%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change			-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$1.328M	-217.3K	-430.5K
YoY Change	-944.22%	-19.51%	174.73%
NET CHANGE
Cash From Operating Activities	-$735.6K	-205.5K	-4.245M
Cash From Investing Activities	$0.00	520.0	2.307M
Cash From Financing Activities	$1.328M	-217.3K	-430.5K
Net Change In Cash	$592.6K	-422.3K	-2.369M
YoY Change	-154.08%	-401.66%	13.82%
FREE CASH FLOW
Cash From Operating Activities	-$735.6K	-$205.5K	-$4.245M
Capital Expenditures	$0.00	-$520.00	$35.81K
Free Cash Flow	-$735.6K	-$205.0K	-$4.281M
YoY Change	-67.57%	-126.97%	-43.68%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	20929	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	271218	usd
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15171748
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15171748
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15021088
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15021088
CY2022Q4	us-gaap	Marketable Securities MarketableSecurities	2336402	usd
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2023	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1	pure
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	37312984	usd
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q4	evtv	Class Of Warrant Or Right Intrinsic Value ClassOfWarrantOrRightIntrinsicValue	0	usd
CY2023	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-38078
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-0774222
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	1425 Ohlendorf Road
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Osceola
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	AR
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	72370
CY2023	dei	City Area Code CityAreaCode	870
CY2023	dei	Local Phone Number LocalPhoneNumber	970-3355
CY2023	dei	Security12b Title Security12bTitle	Common Stock, $0.00001 par value
CY2023	dei	Trading Symbol TradingSymbol	EVTV
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	30300000	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	15520637
CY2023	dei	Auditor Name AuditorName	Barton CPA PLLC
CY2023	dei	Auditor Firm AuditorFirmId	6968
CY2023	dei	Auditor Location AuditorLocation	Cypress, Texas
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	456719	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2765068	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	0	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	60399	usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	0	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	2336402	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	692102	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2073691	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	6830593	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	5671326	usd
CY2023Q4	evtv	Inventory Deposits InventoryDeposits	3300388	usd
CY2022Q4	evtv	Inventory Deposits InventoryDeposits	4829933	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	614238	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	445963	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	162119	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	156457	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	12056159	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	18339239	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	320687	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	368461	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	538932	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0	usd
CY2023Q4	us-gaap	Goodwill Goodwill	9583836	usd
CY2022Q4	us-gaap	Goodwill Goodwill	14682620	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	153555	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	93369	usd
CY2023Q4	us-gaap	Assets Assets	22653169	usd
CY2022Q4	us-gaap	Assets Assets	33483689	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	760802	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	603744	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	452236	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	652528	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	291263	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	0	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	269245	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	215766	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1773546	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1472038	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	235625	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	10420	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	16671	usd
CY2023Q4	us-gaap	Liabilities Liabilities	2019591	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1488709	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	152	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	150	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	85245925	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	83923350	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-64612499	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-51928520	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	20633578	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	31994980	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22653169	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	33483689	usd
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2862853	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	4504621	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	1857273	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	2772673	usd
CY2023	us-gaap	Gross Profit GrossProfit	1005580	usd
CY2022	us-gaap	Gross Profit GrossProfit	1731948	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8171344	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7996906	usd
CY2023	evtv	Consulting Expense ConsultingExpense	213930	usd
CY2022	evtv	Consulting Expense ConsultingExpense	339505	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	236181	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	149912	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	5098784	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	37093047	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	13720239	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	45579370	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-12714659	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-43847422	usd
CY2023	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	34835	usd
CY2022	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	45026	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4155	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1764	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	30680	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	43262	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-12683979	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-43804160	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-0	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-12683979	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-43804160	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.84
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.92
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15061945
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14991837
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	73741864	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	120000	usd
CY2022	evtv	Stock Issued During Period Value Legal Settlements StockIssuedDuringPeriodValueLegalSettlements	322431	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1614845	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-43804160	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	31994980	usd
CY2023	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	100000	usd
CY2023	evtv	Adjustments To Additional Paid In Capital Unearned Compensation AdjustmentsToAdditionalPaidInCapitalUnearnedCompensation	100000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1322577	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-12683979	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	20633578	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-12683979	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-43804160	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	128801	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	97242	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	20929	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	245219	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	1322577	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	1614845	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	5098784	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	37093047	usd
CY2023	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-9904	usd
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	10004	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1360660	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	890880	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1159267	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1820785	usd
CY2023	evtv	Increase Decrease In Inventory Deposits IncreaseDecreaseInInventoryDeposits	-1529545	usd
CY2022	evtv	Increase Decrease In Inventory Deposits IncreaseDecreaseInInventoryDeposits	326854	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-298798	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-325638	usd
CY2023	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	21806	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	156457	usd
CY2023	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	72230	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-143270	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	111838	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	365284	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-189654	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-305065	usd
CY2023	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	0	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-2427	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4245100	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7432087	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	35810	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	168583	usd
CY2023	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	-0	usd
CY2022	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	3942940	usd
CY2023	us-gaap	Proceeds From Sale Maturity And Collection Of Shortterm Investments ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments	2342643	usd
CY2022	us-gaap	Proceeds From Sale Maturity And Collection Of Shortterm Investments ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments	9619242	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2306833	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	5507719	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	120000	usd
CY2023	us-gaap	Proceeds From Repayments Of Debt ProceedsFromRepaymentsOfDebt	-430481	usd
CY2022	us-gaap	Proceeds From Repayments Of Debt ProceedsFromRepaymentsOfDebt	-276690	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-430481	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-156690	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2368748	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2081058	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2825467	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4906525	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	456719	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2825467	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	14997	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	16338	usd
CY2023	us-gaap	Stock Issued1 StockIssued1	0	usd
CY2022	us-gaap	Stock Issued1 StockIssued1	322431	usd
CY2023	evtv	Stock Issued For Services StockIssuedForServices	2	usd
CY2022	evtv	Stock Issued For Services StockIssuedForServices	0	usd
CY2023	us-gaap	Notes Assumed1 NotesAssumed1	467074	usd
CY2022	us-gaap	Notes Assumed1 NotesAssumed1	439087	usd
CY2023	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	usd
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	25007	usd
CY2023	us-gaap	Nature Of Operations NatureOfOperations	<p style="margin: 0pt; line-height: 1.25; font-family: Times New Roman; font-size: 10pt;"><b><em style="font: inherit;">1.</em> Organization and Operations</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Envirotech Vehicles, Inc. (“we,” “us,” “our” or the “Company”) is a provider of purpose-built <em style="font: inherit;">zero</em>-emission electric vehicles focused on reducing the total cost of vehicle ownership and helping fleet operators unlock the benefits of green technology. The Company serves commercial and last-mile fleets, school districts, public and private transportation service companies and colleges and universities to meet the increasing demand for light to heavy-duty electric vehicles. The Company’s vehicles address the challenges of traditional fuel price cost instability and local, state and federal regulatory compliance.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">On <em style="font: inherit;"> June 28, 2022, </em>we effected a <em style="font: inherit;">1</em>-for-20 reverse stock split of our common stock with <em style="font: inherit;">no</em> change to authorized shares of common stock. All share, restricted stock unit (“RSU”), and per share or per RSU information through this Annual Report on Form <em style="font: inherit;">10</em>-K has been retroactively adjusted to reflect the stock split. The shares of common stock retain a par value of $0.00001 per share. Accordingly, an amount equal to the par value of the decreased shares resulting from the reverse stock split was reclassified from “Common stock” to “Additional paid-in capital.”</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">On <em style="font: inherit;"> March 30 2023, </em>the Company entered into an agreement with Berthaphil, Inc. ("Berthaphil") to sublease approximately 3,600 square yards of a warehouse building based in the Clark Freeport Zone in the Philippines. The term of the lease is <span style="-sec-ix-hidden:c109646907">two</span> years and <em style="font: inherit;">two</em> months with a turnover date of <em style="font: inherit;"> July 1, 2023 (</em>"turnover date") and a rental commencement date of <em style="font: inherit;"> September 1, 2023. </em>The Company intends to use the leased space as a production facility as it seeks to expand its business presence both in the region and the United States.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b><i>Use of Estimates</i></b>—The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America ("GAAP") requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"></p>
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	692102	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2073691	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	0	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	60399	usd
CY2023Q4	us-gaap	Marketable Securities MarketableSecurities	0	usd
CY2023Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	713031	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	20929	usd
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	2344909	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	271218	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	6843022	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	6830593	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	5683755	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	12429	usd
CY2023Q4	evtv	Inventory Deposits InventoryDeposits	3300388	usd
CY2022Q4	evtv	Inventory Deposits InventoryDeposits	4829933	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1207888
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1389584
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	608266
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	14202417
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1322577	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1614845	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b><i>Concentration of Credit Risk</i></b>—The Company has credit risks related to cash and cash equivalents on deposit with a federally insured bank, as at times it exceeds the <em style="font: inherit;">$250,000</em> maximum amount insured by the Federal Deposit Insurance Corporation (“FDIC”). Between FDIC and the Securities Investor Protection Corporation (“SIPC”) coverage, funds up to $750,000, which <em style="font: inherit;"> may </em>include cash up to $500,000, are insured. </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Company’s bank requires compensating balances, which are reported as Restricted Cash on the Company's Consolidated Balance Sheets as disclosed above, for a subsidiary’s potential lease exposure and for the Company’s credit card limit, resulting in restricted cash of $0 and approximately $60,399 at <em style="font: inherit;"> December 31, 2023 </em>and <em style="font: inherit;">2022</em>, respectively.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"></p>
CY2023Q4	evtv	Maximum Insured Funds Fdic And Spic MaximumInsuredFundsFdicAndSpic	750000	usd
CY2023Q4	evtv	Maximum Cash Insured MaximumCashInsured	500000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	60399	usd
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	236181	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	149912	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	5098784	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	37093047	usd
CY2021Q4	us-gaap	Goodwill Goodwill	51775667	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	37093047	usd
CY2022Q4	us-gaap	Goodwill Goodwill	14682620	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	5098784	usd
CY2023Q4	us-gaap	Goodwill Goodwill	9583836	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2023Q4	evtv	Operating Loss Carryforwards Net OperatingLossCarryforwardsNet	44188133	usd
CY2022Q4	evtv	Operating Loss Carryforwards Net OperatingLossCarryforwardsNet	37312984	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	694645	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	613618	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	373958	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	245157	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	320687	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	368461	usd
CY2023	us-gaap	Depreciation Depreciation	128801	usd
CY2022	us-gaap	Depreciation Depreciation	97242	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	44188133	usd
CY2023Q4	evtv	Operating Loss Carryforwards Not Subject To Expiration OperatingLossCarryforwardsNotSubjectToExpiration	29810794	usd
CY2023Q4	evtv	Operating Loss Carryforwards Subject To Expiration OperatingLossCarryforwardsSubjectToExpiration	14377339	usd
CY2023Q4	evtv	Tax Effected Net Operating Loss TaxEffectedNetOperatingLoss	1361609	usd
CY2022Q4	evtv	Tax Effected Net Operating Loss TaxEffectedNetOperatingLoss	1169392	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	7917898	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	6666335	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	274891	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	274891	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	9554398	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	8110618	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	9554398	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	8110618	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	269245	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	6252	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	4167	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	279664	usd
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15171748
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15021088
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1389584
CY2023Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	17.43
CY2023	evtv	Class Of Warrant Or Right Exercisable Weighted Average Remaining Contractual Life ClassOfWarrantOrRightExercisableWeightedAverageRemainingContractualLife	P1Y11M4D
CY2023Q4	evtv	Class Of Warrant Or Right Intrinsic Value ClassOfWarrantOrRightIntrinsicValue	0	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	338500
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8.4
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y11M23D
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	50000
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.4
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	25000
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	9
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	608266
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	608266
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.3
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y6M7D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1207888
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1207888
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.71
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y6M10D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1196220
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.72
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P8Y6M7D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.71
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	538932	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	291263	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	235625	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	89268	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	61380	usd
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	188921	usd
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	167367	usd
CY2023	us-gaap	Lease Cost LeaseCost	278189	usd
CY2022	us-gaap	Lease Cost LeaseCost	228747	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	101312	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	45767	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.14	pure
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	346972	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	248873	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	595845	usd

Files In Submission

Name	View Source	Status
0001437749-24-009818-index-headers.html	Edgar Link	pending
0001437749-24-009818-index.html	Edgar Link	pending
0001437749-24-009818.txt	Edgar Link	pending
0001437749-24-009818-xbrl.zip	Edgar Link	pending
adom20231231_10k.htm	Edgar Link	pending
evtv-20231231.xsd	Edgar Link	pending
ex_600074.htm	Edgar Link	pending
ex_600075.htm	Edgar Link	pending
ex_600077.htm	Edgar Link	pending
ex_600078.htm	Edgar Link	pending
ex_600079.htm	Edgar Link	pending
ex_642121.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image01.jpg	Edgar Link	pending
image02.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
evtv-20231231_def.xml	Edgar Link	unprocessable
evtv-20231231_lab.xml	Edgar Link	unprocessable
evtv-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
adom20231231_10k_htm.xml	Edgar Link	completed
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
evtv-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EVTV
Envirotech Vehicles, Inc. Stock $evtv

2024 Q1 Form 10-K Financial Statement

#000143774924009818 Filed on March 28, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EVTV Envirotech Vehicles, Inc. Stock $evtv

2024 Q1 Form 10-K Financial Statement

#000143774924009818 Filed on March 28, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EVTV
Envirotech Vehicles, Inc. Stock $evtv